Gordian Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
4,359
+3
+0.1% +$699 0.65% 13
2026
Q1
$1.06M Buy
4,356
+58
+1% +$13.5K 0.71% 13
2025
Q4
$889K Sell
4,298
-96
-2% -$19K 0.59% 15
2025
Q3
$815K Buy
4,394
+4
+0.1% +$685 0.55% 15
2025
Q2
$671K Buy
4,390
+1,004
+30% +$154K 0.48% 16
2025
Q1
$561K Buy
3,386
+4
+0.1% +$626 0.45% 16
2024
Q4
$489K Buy
3,382
+5
+0.1% +$775 0.39% 16
2024
Q3
$547K Buy
+3,377
New +$538K 0.44% 16

Other funds holding JNJ

Gordian Advisors's JNJ Position: Q2 2026 in Review

Gordian Advisors increased its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, buying an estimated $699 and bringing the position to 4,359 shares worth $1.11M. The position accounts for 0.65% of the portfolio, ranked #13.

Gordian Advisors first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gordian Advisors held 4,359 shares of Johnson & Johnson worth $1.11M as of Q2 2026.
  • Gordian Advisors bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
  • Johnson & Johnson made up 0.65% of Gordian Advisors's portfolio in Q2 2026, its #13 holding.
  • Gordian Advisors first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gordian Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.